Corrigendum to "Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo" [Nanomedicine: Nanotechnology, Biology, and Medicine 11 (2015) 1277-1283].

Wolfe, Tatiana; Chatterjee, Dev; Lee, Jihyoun; Grant, Jonathan D; Bhattarai, Shanta; Tailor, Ramesh; Goodrich, Glenn; Nicolucci, Patricia; Krishnan, Sunil

Wolfe, Tatiana; Chatterjee, Dev; Lee, Jihyoun; Grant, Jonathan D; Bhattarai, Shanta; Tailor, Ramesh; Goodrich, Glenn; Nicolucci, Patricia; Krishnan, Sunil.

Afiliación

Wolfe T; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chatterjee D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA; SoonChunHyang University Hospital, Seoul, South Korea.
Grant JD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bhattarai S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tailor R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Goodrich G; Nanospectra Biosciences Inc., Houston, TX, USA.
Nicolucci P; University of Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil.
Krishnan S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: skrishnan@mdanderson.org.

Nanomedicine ; 12(3): 851-852, 2016 Apr.

Article en En | MEDLINE | ID: mdl-27018259

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google